ISRCTN10999269进行中（未招募）未知
Personalized Hypertension Management (PHMA) based on serial assessment and telemedicine in Anhui, China
ational Natural Science Foundation of China0 个研究点目标入组 3,420 人开始时间: 2020年7月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 3,420
研究概览
简要总结
2021 protocol in https://pubmed.ncbi.nlm.nih.gov/33711941/ (added 15/03/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged =18 years
- •2. Living in the selected villages for =6 months/year
- •3. Diagnosed with hypertension
排除标准
- •Previous diagnosis of mental illness, serious illness, or disability
研究者
相似试验
已完成
4 期
Personalised Electronic Record Supported Optimisation When Alone for Patients With HypertensionHypertensionNCT04559074Queen Mary University of London343
已完成
不适用
A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomised study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design.Essential Hypertension grade I and IICirculatory SystemHypertensionISRCTN55725285Solvay Pharmaceuticals (Germany)
招募中
不适用
Personalized hemodynamically guided antihypertensive treatment in pregnant women with mild to moderate hypertension: a randomized controlled trialgestational hypertensionpregnancy-induced-hypertension1001027310057166NL-OMON53093Medisch Universitair Ziekenhuis Maastricht368
已完成
不适用
FimasaRtan-basEd BP Targets After Drug SwitcHingEssential HypertensionNCT03649646Boryung Pharmaceutical Co., Ltd4,542
进行中（未招募）
4 期
Optimising treatment for mild systolic hypertension in the elderly - long-term follow-upSpecialty: Primary Care, Primary sub-specialty: AgeingUKCRC code/ Disease: Cardiovascular/ Hypertensive diseasesCirculatory SystemHypertensionISRCTN97503221niversity of Oxford569